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It takes time to recognise the differences between a literature
search (LS), a literature review (LR), a systematic review (SR) and
a meta-analysis (MA), especially as these terms are often used
interchangeably by many authors. For example, a colleague said
recently that she planned to do SR as part of her background for
her post-graduate research thesis. She planned to have it
completed within five days. After talking to her, it was clear that
she did not understand the concept (or the workload!) involved in
a SR. On the other hand, we all do so-called “quick and dirty” LSs
every day! Those are the kind of search where you have a
question, you open up your favourite search engine (PubMed,
EMBASE, etc.), plug in a few key words and press “search”.
Usually, with this type of search, you only put more effort into the
search strategy if the “quick and dirty” approach does not yield
enough (or any) relevant articles or if you are doing the LR for
your thesis, or research project.
So, what are the differences between LS, LR, SR and MA?
Actually, they can be described along a continuum, where
literature search is the most basic and SR the most complex, with
a MA the statistical extension of a systematic review where
appropriate. A narrative (literature) review is a review of various
articles, but generally lacks explicit descriptions of systematic
methods to identify articles and/or failure to critically appraise
them. Let us start by discussing each term.
A literature search means exactly what it implies: you search
the literature to answer a question, e.g., “What is Giardiasis?” You
can open the book on infectious diseases, check MEDLINE or
search Google in order to come across one summary article that
gives you a general idea of what Giardiasis is. In experienced
hands, this will take only a few minutes and you gain some
superficial knowledge. (Alternatively you could spend months
searching for every article written in the medical and non-medical
literature on Giardia, but you will have still only searched the
literature; you may not have any more information on Giardia than
when you started).
Generally, when doing a literature review, a search strategy is
drawn up and one or more medical databases is used to
implement the search strategy. (A search strategy incorporates
the issues, such as PICOT, previously discussed in our “What’s the
difference between PubMed and MEDLINE?” tutorial.) As part of
a literature review, it is expected that the retrieved articles are
reviewed (i.e., critically appraised) and not just superficially read.
A Systematic Review is a scientific investigation, a research
article with pre-defined systematic methods that identify
systematically articles relevant to the research question, appraise
their quality, extract data and then synthesise the results of these
articles. The original studies which make up a SR (including
published and unpublished data, conference proceedings,
abstracts, etc.) are the “subjects” of the scientific systematic
review. A SR employs methods to limit bias and random error. In a
SR, the results of primary studies will be summarized, but may or
may not be statistically combined to give a final figure. When
statistical methods are used to combine the results of two or more
studies, this is called a Meta-Analysis.
Let’s summarise to date:
• Literature search: searching the literature for some
studies.
• Literature review: reviewing the studies which have been
identified.
• Systematic review: systematically searching the literature
to identify all relevant published and unpublished data in
order to appraise their quality and summarise the overall
findings. If the studies are homogeneous (similar), and of
sufficient quality, then their results can be amalgamated into
a meta-analysis in order to obtain one final result
summarising all the included studies.
Why is a systematic review considered to be the highest
level of evidence?
Simply because a well-designed SR will summarise good quality
randomised controlled trials (or, increasingly these days,
observational studies). Let’s go through how you could perform a
SR. If you understand the concepts and steps behind performing
a SR, it will help when trying to read and appraise them.
Planning
Firstly, you have to have a question that you want to answer. And it
helps if it is your question rather than your supervisor’s question,
as it is likely that you will read and appraise all the articles, while
your supervisor supervises! Then, the question must be framed as
a research question, in the PICOT format. For this, you should try
to come up with every synonym for all the elements of your
PICOT. After this, some people will design their own way of
searching the literature systematically, and others will use some of
the pre-validated search strategies available (e.g., search
strategies for retrieving randomised controlled trials from
MEDLINE1 and PubMed2). When planning the search, be careful
not to make it too wide (or you will have a huge number of false-
negative articles: imagine searching for all the treatments of a
heart attack) or too narrow (where you are likely to miss many
articles that would be relevant to your question). This is the
planning stage, and the more you plan , the more time you can
save later (if your search is not too big) or the more likely you are
to find the articles that really answer your question (if your search
is not too small).
Next, you should define your inclusion and exclusion criteria. For
example, do you want to include only randomised controlled
double blind clinical trials, or does blinding not matter? Or, if it is
unlikely that you will find RCTs, will you accept cohort or case
control studies? Is there an age limit appropriate to your
participants for included studies? What about exclusion criteria?
Predefining your inclusion and exclusion criteria helps to prevent
against bias when reviewing your articles for inclusion in your SR.
Searching for evidence
Once you have planned your search and inclusion and exclusion
criteria, now you implement your search strategy. Different
databases will be more relevant to different searches. There is
overlap between MEDLINE (www.ncbi.nlm.nih.gov/pubmed) and
EMBASE (www.embase.com), so performing your search in both
might not add a significant number of articles. However, some
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European journals might be indexed in
EMBASE, but not in MEDLINE. Searching in
the Cochrane Controlled Trials Register
(www.cochrane.org) might be very helpful for
RCTs, whereas for nursing it may be best to
search in CINAHL (www.ebscohost.com), and





At this stage, all articles that have been
retrieved by the search are analysed for the
predefined inclusion and exclusion criteria. In
some cases, review of the title and abstract may
be sufficient to exclude some articles. In other
cases, the article will need to be reviewed in
detail (the number of studies excluded at each
of these stages are generally shown as the first
figure in good SRs). Next, data extraction is
performed on all studies that you think should be included. Data
extraction should be exhaustive3, because all valuable information
should be retrieved from studies at this stage so that there is
often no need to refer back to the original studies. It is worth
noting that some studies will be excluded during the data
extraction stage. Review of titles, abstracts and entire studies, and
data extraction are best performed independently by two
reviewers, in order to reduce bias.4 Care should be taken to note
the study design when extracting the data as results from
different study designs are not always directly comparable.
Quality appraisal
The next step is to critically appraise the studies by comparing
and contrasting studies that are included in the final systematic
review. Comments should also be made on sources of (potential)
bias and specific areas of interest such as publication bias, ethics,
quality analysis of included studies and comments on specific
areas of your results, as required – for example, analyses
performed according to years of publication of studies might be
appropriate if, say, a new treatment was released during that
period. (Basically, you are looking for are good quality studies in
order to form a good quality SR).
Is it appropriate to do a meta-analysis?
MA is a statistical method of combing the results of studies
included in a SR so that an overall treatment effect can be
ascertained. Care should be taken with MA –strict criteria should
be observed, and consultation with experts may be required, to
prevent heterogeneity of included studies (i.e., to prevent
comparing ‘apples’ with ‘oranges’). One of the results of MA is the
generation of a “forest plot”. When interpreting a forest plot, look
for the following (Figures 1 and 2).
There are several types of meta-analysis. For example, random
effects models are used when there is thought to be significant
heterogeneity (differences) between studies, but fixed effects
models are used when there is less heterogeneity, and Peto’s
models are used for meta-analyses with very small sample sizes.
Using the wrong method in the wrong circumstances can lead to
different, and therefore incorrect, conclusions. It has also been
pointed out by some statisticians that it is safer to assume
‘random’ effects in all meta-analyses, as the tests for homogeneity
are of low power. Also, the effects of publication bias – where
mainly positive results were published – needs to be assessed
when interpreting the results.
No discussion of systematic reviews is complete without
acknowledging the Cochrane Collaboration, named after Archie
Cochrane, a Scottish medical researcher and pioneer of evidence-
based medicine (www.cochrane.org). This is an international
organization that publishes rigorous SRs evaluating the
effectiveness of a wide range of health care interventions. The
Cochrane Collaboration standardises, by means of expert review
groups, the quality and methodology of SRs and MAs, and it
encourages regular updates of its published SRs and MAs. (In
fact, the symbol of the Cochrane Collaboration is the forest plot
from one of the first MAs; this showed that antenatal steroids
improved perinatal outcome and, thus, profoundly changed
obstetrical management and reduced neonatal mortality and
morbidity worldwide.6) This is the real strength of a SR and MA: to
show an overall treatment effect which is stronger than the
individual treatment effects of any included trials, even when the
individual included trials show no overall effect. A further
cautionary note is required here, remembering that in the past
there was a certain publication bias for positive results. Some
MAs, conducted using studies published during periods when this
this publication bias was common, may have produced inaccurate
results and treatments may have been changed to the detriment
of patients. Large trials (RCTs) are always to be preferred, when
possible. And, in the future, it is hoped that efforts to counteract
publication bias (with the consequent publication of negative
trials) will mean that future MAs will include inputs from trials with
both positive and negative results.
We hope that this paper helps you to understand the methodology
of SR and MA, and to appraise published data. This paper alone is
not sufficient to train you to perform SR and MA, but if you are
now inspired and would like to learn more, there are plenty of
courses that would be very helpful. However, we do hope that in
explaining the complexity of performing a systematic review we
have helped you to appreciate why it is valued so as a research
tool.
A more complicated MA using six studies to analyse the effect of
an intervention (experiment) compared to placebo
(control) showing no difference between the groups.
Note however that two studies (O’Gorman and
Macken) cross the line of “no effect” suggesting that
there was no difference, two favour the intervention
(Aiden and Eve) and two favour the control (Higgins
and Saunders).
Box 1: Listed are some resources that you could
access for more information. However, we learned
Figure 2 More complex Forest Plot
– the size of each box represents the weight of each individual study;
– the position of the box in relation to the line of no effect represents the treatment effect of
each individual study;
– the size of the whiskers (the lines extending from the boxes) represent the confidence
interval around the treatment effect for each individual study;
– the size and position of the diamond indicate the overall treatment effect of the meta-
analysis, and the confidence interval around that treatment effect.
Figure 1 Simple Forest Plot
Forest plot showing that one study was analysed with no difference
between groups. Mantel Hanzel with odds ratio crossing one.
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about SRs and MAs by reading, helping to design them and doing
them! An excellent resource is The Cochrane Collaboration, which
regularly runs seminars on how to do a systematic review.
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Statistics are essential components of quantitative (and
qualitative) research that we all should know. We have sat through
numerous lectures on the subject, and we know that we need to
understand it and really should by now, even if only to not appear
un-knowledgeable at journal club meetings. Still many people
skip the section on statistical analysis when reading papers.
Sometimes it feels that only those who have performed full time
research really understand statistics - and not even then if they
were lucky enough to have a statistician on their team. As part of
our series of research tutorials we would now like to remove some
of the mystery surrounding the art of statistics. Let’s start with the
raw data….
What’s the difference between qualitative and quantitative data?
As you begin your analysis you will always have a body of raw
data which you can then use to reject or accept a null hypothesis.
(Remember the Null Hypothesis? It is the chance that there is no
difference between the groups being compared.) Before deciding
which test you are going to use, you need to first decide what kind
of data you are going to collect. Data are either qualitative (e.g.,
colour of hair, type of job, place of birth, “quality” information) or
quantitative (e.g., BP readings, serum bilirubin levels, birth weight:
quantities, numbers). While that seems relatively easy, some
people will try and confuse you by referring to qualitative data as
categorical or to quantitative data as numerical. We are going to
keep it simple, and we suggest that you stick with the simple
subtypes and then take it from there.
What’s the difference between parametric and non-parametric
data?
Remember the famous Gaussian curve of the normal distribution?
If not, look at Figure 1, and it will immediately spring to mind again.
A normal distribution is symmetrically distributed around the mean
with a bell-shaped curve. If
your data are normally
distributed, then you can
use tests based on the
normal distribution (such
as the t-test: more on this
later); if the data are not
normally distributed (i.e.,
non-parametric, or
skewed) then you can
either transform to normal




tools to convert “not-normally” distributed data to normally
distributed data, e.g., data that are positively skewed (i.e., skewed
to the right) might be transformed by getting the logarithmic of
each individual data in the dataset. (However this is risky as the
hypothesis being tested will also change).
What’s the difference between average, mean, mode and median?
Primary level maths taught us all the meaning of the term
“average”. The mean, mode and median may be different numbers
but all represent the average value of data. Essentially, the mean
is the arithmetic mean (the sum of all the values divided by the
number of values), the median is the middle number in a series of
numbers (thus, dividing the distribution in half), and the mode is
the value that occurs most often (I think of it as being fashionable,
or “in mode”, so it is repeated most often). Here are a couple of
examples, from this group of numbers, or raw data. This could be
ages, or grammes of medication required to get an effect, or
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Figure 1: Gaussian curve: normally
distributed population
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